Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Other Operating Expenses (2023 - 2025)

Bioventus (BVS) has disclosed Other Operating Expenses for 3 consecutive years, with $1000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to $1000.0, compared with a TTM value of -$81000.0 through Dec 2025, up 72.26%, and an annual FY2025 reading of -$81000.0, up 72.26% over the prior year.
  • Other Operating Expenses was $1000.0 for Q3 2025 at Bioventus, up from -$1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1000.0 in Q3 2025 and bottomed at -$1.4 million in Q3 2023.
  • Average Other Operating Expenses over 3 years is -$564285.7, with a median of -$292000.0 recorded in 2024.
  • Peak annual rise in Other Operating Expenses hit 75.59% in 2024, while the deepest fall reached 75.59% in 2024.
  • Year by year, Other Operating Expenses stood at -$1.2 million in 2023, then surged by 75.59% to -$292000.0 in 2024, then soared by 100.34% to $1000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for BVS at $1000.0 in Q3 2025, -$1000.0 in Q2 2025, and -$81000.0 in Q1 2025.